Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Huston

Showing results (321-330 of 562) with videos related to

Pageof 57
Sort By:
Peptides|June 27, 2002
Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata)Marilia Barros, M A De Souza Silva, Joseph P Huston, et al.
Neurobiology of Learning and Memory|June 17, 2008
NK(3) receptor agonism promotes episodic-like memory in miceArmin Zlomuzica, Ekrem Dere, Joseph P Huston, et al.
Behavioural Brain Research|January 31, 1994
Unilateral stimulation or removal of rat vibrissae: analysis of nerve growth factor and tyrosine hydroxylase mRNA in the brainR K Schwarting, G Pei, S Söderström, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
How is an international public health threat advanced in Canada? The case of antimicrobial resistanceL Tsegaye, P Huston, R Milliken, et al.
Southern Medical Journal|July 1, 1987
Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritisR E Sims, F E Rushford, D P Huston, et al.
Experientia|March 15, 1974
Hypothalamic self-stimulation during light anesthesia in the ratH V Lörcher, A A Borbély, P G Waser, et al.
Pharmacology & Therapeutics|July 13, 2002
Interleukins-4, -5, and -13: emerging therapeutic targets in allergic diseasePaul S Foster, Margarita Martinez-Moczygemba, David P Huston, et al.
Peptides|January 1, 1997
Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesionS Nikolaus, J P Huston, B Körber, et al.
Transactions of the American Clinical and Climatological Association|July 6, 2000
Interleukin-5, a therapeutic target in allergic inflammationD P Huston, M M Huston, R R Dickason, et al.
Neuroscience|December 7, 2011
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundleO Y Chao, M E Pum, J-S Li, et al.
Pageof 57

Showing results (321-330 of 562) with videos related to

Sort By:
Pageof 57
Peptides|June 27, 2002
Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata)Marilia Barros, M A De Souza Silva, Joseph P Huston, et al.
Neurobiology of Learning and Memory|June 17, 2008
NK(3) receptor agonism promotes episodic-like memory in miceArmin Zlomuzica, Ekrem Dere, Joseph P Huston, et al.
Behavioural Brain Research|January 31, 1994
Unilateral stimulation or removal of rat vibrissae: analysis of nerve growth factor and tyrosine hydroxylase mRNA in the brainR K Schwarting, G Pei, S Söderström, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
How is an international public health threat advanced in Canada? The case of antimicrobial resistanceL Tsegaye, P Huston, R Milliken, et al.
Southern Medical Journal|July 1, 1987
Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritisR E Sims, F E Rushford, D P Huston, et al.
Experientia|March 15, 1974
Hypothalamic self-stimulation during light anesthesia in the ratH V Lörcher, A A Borbély, P G Waser, et al.
Pharmacology & Therapeutics|July 13, 2002
Interleukins-4, -5, and -13: emerging therapeutic targets in allergic diseasePaul S Foster, Margarita Martinez-Moczygemba, David P Huston, et al.
Peptides|January 1, 1997
Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesionS Nikolaus, J P Huston, B Körber, et al.
Transactions of the American Clinical and Climatological Association|July 6, 2000
Interleukin-5, a therapeutic target in allergic inflammationD P Huston, M M Huston, R R Dickason, et al.
Neuroscience|December 7, 2011
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundleO Y Chao, M E Pum, J-S Li, et al.
Pageof 57